Wegovy and Birth Control: Does Semaglutide Affect the Pill?

Short answer: Wegovy (semaglutide) does not appear to make oral birth control less effective. Its current FDA label is direct about this: in the clinical pharmacology trials that tested it, "semaglutide did not affect the absorption of orally administered medications."^[1] That includes a dedicated pharmacokinetic study of a combined oral contraceptive (ethinylestradiol/levonorgestrel), which found no clinically relevant change in exposure.^[1][4] This is the opposite of Mounjaro and Zepbound (tirzepatide), whose label does warn that oral contraceptives may be less effective and instructs patients to switch to a non-oral method or add a barrier method for 4 weeks after starting and after every dose increase.^[2] A peer-reviewed pharmacology review confirmed the split is real: tirzepatide measurably lowered oral-contraceptive exposure, while the GLP-1 receptor agonists studied — semaglutide among them — did not.^[5][6] Still, two real cautions apply to Wegovy users: if its gastrointestinal side effects make you vomit or have diarrhea, that can reduce how much of an oral pill you absorb; and because semaglutide may harm a developing fetus, pregnancy must be avoided on it — which is exactly why reliable contraception still matters. Wegovy is semaglutide at the weight-management dose; see our Wegovy drug page and the related Wegovy vs. semaglutide disambiguation. This is general educational information, not medical advice — your prescriber manages your care.

Does Wegovy make birth control less effective?

Based on the current label, no — Wegovy is not expected to reduce the effectiveness of oral contraceptives. Section 7.2 of the Wegovy prescribing information reads: "WEGOVY causes a delay of gastric emptying and thereby has the potential to impact the absorption of concomitantly administered oral medications. In clinical pharmacology trials with semaglutide 1 mg, semaglutide did not affect the absorption of orally administered medications." The label goes on to say prescribers should "monitor the effects of oral medications concomitantly administered with WEGOVY" as a general precaution — but it does not single out oral contraceptives, and it does not instruct patients to use a backup method or switch to a non-oral form.^[1]

That general statement is backed by specific data. Section 12.3 of the label describes a drug-interaction study conducted at semaglutide 1 mg steady-state exposure that directly measured the effect on a combined oral contraceptive: "Metformin and oral contraceptive drug (ethinylestradiol/levonorgestrel) were assessed at steady state." The accompanying exposure figure shows no clinically relevant shift in ethinylestradiol or levonorgestrel AUC or Cmax when co-administered with semaglutide, and the label concludes "No clinically relevant drug-drug interactions with semaglutide... were observed based on the evaluated medications." The label adds that "in a separate study, no apparent effect on the rate of gastric emptying was observed with semaglutide 2.4 mg" — the actual Wegovy maintenance dose.^[1]

A published pharmacokinetic study behind this data — testing semaglutide against the same ethinylestradiol/levonorgestrel combination in healthy women — reported that semaglutide "does not reduce the bioavailability" of the pill.^[4] And a broader peer-reviewed review of GLP-1 medicines and oral hormonal contraception concluded that the GLP-1 receptor agonists it examined — the class semaglutide belongs to — did not produce a clinically meaningful reduction in oral-contraceptive blood levels, unlike tirzepatide.^[5] A second, more recent pharmacology review of approved GLP-1 and GIP/GLP-1 drugs reached the same conclusion.^[6] In other words, the theoretical mechanism (slowed gastric emptying can delay absorption of anything swallowed) exists for the whole drug class, but for semaglutide the actual measured data and the label both say it does not translate into a contraceptive problem.

Why Mounjaro and Zepbound (tirzepatide) are the real exception

Here is the contrast that trips people up: Mounjaro and Zepbound are tirzepatide, not semaglutide, and their label carries an explicit contraceptive warning that the Wegovy label does not. Tirzepatide is a dual GIP/GLP-1 receptor agonist, and its own label states plainly: "Use of ZEPBOUND may reduce the efficacy of oral hormonal contraceptives due to delayed gastric emptying. This delay is largest after the first dose and diminishes over time."^[2] That is a materially stronger and more specific statement than anything in the Wegovy label.

Because of that measured effect, the tirzepatide label instructs: "Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method, or add a barrier method of contraception for 4 weeks after initiation with ZEPBOUND and for 4 weeks after each dose escalation."^[2][3] The pharmacology reviews cited above confirm this is a real, tirzepatide-specific effect — one study found tirzepatide reduced oral-contraceptive Cmax by roughly 59% and AUC by roughly 20% after a single dose, a large enough shift that the FDA required the warning.^[5][6] Nothing comparable appears in semaglutide's pharmacokinetic data. If you are on Mounjaro or Zepbound rather than Wegovy or Ozempic, this warning applies to you and is worth taking seriously — see our companion piece on Mounjaro and birth control.

The two cautions that still apply on Wegovy

Even though Wegovy itself is not expected to weaken the pill, two practical issues mean contraception still deserves attention while you are taking it.

1. Vomiting and diarrhea can reduce pill absorption

Nausea, vomiting, and diarrhea are among the most common Wegovy side effects, especially in the first weeks and after a dose increase.^[1] An oral contraceptive only works if you actually absorb it — so a bout of significant vomiting or diarrhea can lower the amount of pill that reaches your bloodstream, independent of anything specific to semaglutide. Standard contraceptive guidance (not specific to Wegovy) is that if you vomit within roughly two to three hours of taking your pill, you should treat that as a missed dose and follow the missed-pill instructions for your specific product; severe or prolonged diarrhea is handled the same way.

• If you vomit within about 2 to 3 hours of taking an oral contraceptive, follow your pill's missed-dose instructions and consider a backup method (such as condoms) until you are back on track.
• If you have severe or prolonged diarrhea, treat it like a missed dose for that pill window, and use a backup method until things settle.
• If GI side effects are frequent or severe, talk to your prescriber — a slower dose titration may reduce them, or a non-oral contraceptive (IUD, implant, injection, patch, or ring) sidesteps the absorption problem entirely because it does not rely on your gut.
• Always read the missed-pill section of your contraceptive's package insert — instructions differ between combined and progestin-only pills.

2. Pregnancy must be avoided on Wegovy

This is the reason reliable contraception matters so much on Wegovy: weight loss offers no benefit to a pregnant patient and may cause fetal harm, and the label advises that "when a pregnancy is recognized," Wegovy should be discontinued.^[1] Animal reproduction studies showed embryofetal mortality, structural abnormalities, and growth alterations at maternal exposures at or below the maximum recommended human dose. Because of semaglutide's long half-life, the label's Section 8.3 specifically advises that females of reproductive potential should discontinue Wegovy at least 2 months before they plan to become pregnant "to account for the long half-life of semaglutide."^[1] So the goal while you are on Wegovy is to prevent pregnancy reliably, then plan a deliberate washout before trying to conceive.

What to do — practical, prescriber-directed steps

Whether you are on semaglutide or tirzepatide, the safe move is to make contraception a planned part of your treatment rather than an afterthought. The steps below are general and prescriber-directed — do not change your medication or your birth control on your own.

• Tell your prescriber what contraception you use. This should be part of starting any GLP-1 or GIP/GLP-1 medicine, so they can flag the tirzepatide oral-contraceptive interaction or any other concern up front.
• If you are on Mounjaro or Zepbound (tirzepatide) instead: follow the label — add a barrier method or switch to a non-oral method for 4 weeks after starting and after each dose increase.^[2][3]
• On Wegovy with severe GI side effects: consider asking about a non-oral method (IUD, implant, injection, patch, or ring), which does not depend on gut absorption and removes the vomiting-and-diarrhea worry.
• Do not stop your birth control to "be safe" — that increases pregnancy risk, which is the very thing to avoid on Wegovy. The goal is reliable contraception, not no contraception.
• Plan the washout before pregnancy. Stop Wegovy at least 2 months before trying to conceive, on your prescriber's schedule, and keep using contraception until then.^[1]
• Read your pill's missed-dose instructions so you know exactly what to do after vomiting or diarrhea, and keep a backup method on hand.

If you are choosing where to start or continue Wegovy under proper supervision, compare the best semaglutide providers, or read our reviews of Found and Ro. A legitimate provider takes a full medication and contraception history, titrates you on the label schedule, and counsels you on pregnancy prevention — exactly the oversight that keeps treatment safe. For the diabetes-brand version of this same drug, see our companion guide, Ozempic and birth control, and for the broader class comparison, see GLP-1s and birth control across the whole drug class.